BEATBio Lands $2,500,000 Seed Financing Round
- Feed Type
- Link
http://www.venturedeal.com/Search/SearchResultTransactionDetail.aspx?TransactionId=29c1c206-b73a-4e02-b3a0-05c5187e634b&Preview=1 - Date
4/17/2013 - Company Name
BEATBio - Mailing Address
Undisclosed Seattle, WA 98101 - Company Description
BEAT BioTherapeutics Corp. (BEATBio) is a Seattle, WA based biotechnology company founded to develop novel therapies for heart disease. BEAT Bio’s first product is based on a fundamental discovery in cardiac muscle contraction and the development of a novel GeneTherapy to improve cardiac performance in the setting of heart failure. - Website
http://www.beatbiotherapeutics.com - Transaction Type
Venture Equity - Transaction Amount
$2,500,000 - Transaction Round
Seed - Proceeds Purposes
The proceeds will be used to move BEATBio’s lead gene therapy product into clinical development. - M&A Terms
- Venture Investor
CET Capital Partners - Venture Investor
W Fund
